Athyrium Opportunities III Co-Invest 1 LP

Insider Reports History

Entity
Company
Location
505 Fifth Avenue, Floor 18, New York, NY
Signature
/s/ Athyrium Opportunities III Co-Invest 1 LP, by Athyrium Opportunities Associates Co-Invest LLC, its general partner, by Andrew Hyman, Senior Vice President, Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Athyrium Opportunities III Co-Invest 1 LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIORA THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 10.9M $34.3M $3.14 Sep 18, 2023 Indirect
BIORA THERAPEUTICS, INC. Director, 10%+ Owner Warrant 457K $1.13M $2.47 Aug 12, 2024 Indirect
BIORA THERAPEUTICS, INC. Director, 10%+ Owner 7.25% Convertible Senior Notes due 2025 0 Dec 18, 2023 Indirect
BIORA THERAPEUTICS, INC. Director, 10%+ Owner 11.00%/13. 00% Convertible Senior Secured Notes due 2028 $18.4M Aug 12, 2024 Indirect

Insider Reports Filed by Athyrium Opportunities III Co-Invest 1 LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BIOR BIORA THERAPEUTICS, INC. Aug 12, 2024 12 $0 4 Aug 14, 2024 Director, 10%+ Owner
BIOR BIORA THERAPEUTICS, INC. Jul 3, 2024 1 $0 4 Jul 8, 2024 Director, 10%+ Owner
BIOR BIORA THERAPEUTICS, INC. Jul 2, 2024 1 $1.02M 4 Jul 5, 2024 Director, 10%+ Owner
BIOR BIORA THERAPEUTICS, INC. Dec 18, 2023 5 $0 4 Dec 20, 2023 Director, 10%+ Owner
BIOR BIORA THERAPEUTICS, INC. Sep 18, 2023 4 $0 4 Sep 19, 2023 Director, 10%+ Owner
BIOR BIORA THERAPEUTICS, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 10%+ Owner
BIOR BIORA THERAPEUTICS, INC. Nov 9, 2022 4 $0 4 Nov 14, 2022 10%+ Owner